• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

CSACI position statement: prescribing sublingual immunotherapy tablets for aeroallergens.

作者信息

Quirt J, Gagnon R, Ellis A K, Kim H L

机构信息

McMaster University, Hamilton, Canada.

Laval University, Quebec City, Canada.

出版信息

Allergy Asthma Clin Immunol. 2018 Jan 9;14:1. doi: 10.1186/s13223-017-0225-6. eCollection 2018.

DOI:10.1186/s13223-017-0225-6
PMID:29339956
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5759887/
Abstract
摘要

相似文献

1
CSACI position statement: prescribing sublingual immunotherapy tablets for aeroallergens.加拿大过敏、临床免疫与变态反应学会立场声明：舌下含服变应原免疫治疗片剂的处方开具
Allergy Asthma Clin Immunol. 2018 Jan 9;14:1. doi: 10.1186/s13223-017-0225-6. eCollection 2018.
2
CSACI position statement: epinephrine auto-injectors and children < 15 kg.加拿大过敏、临床免疫与变态反应学会立场声明：肾上腺素自动注射器与体重＜15千克的儿童
Allergy Asthma Clin Immunol. 2015 Jun 12;11(1):20. doi: 10.1186/s13223-015-0086-9. eCollection 2015.
3
The Effective Allergenic Reactivity of House Dust Mite Sublingual Immunotherapy Tablets Is Determined by Tablet Formulation.屋尘螨舌下免疫治疗片剂的有效变应原反应性由片剂配方决定。
Biol Pharm Bull. 2019;42(6):1030-1033. doi: 10.1248/bpb.b18-00857.
4
Allergy immunotherapy prescribing trends for grass pollen-induced allergic rhinitis in Germany: a retrospective cohort analysis.德国草花粉诱发过敏性鼻炎的过敏免疫疗法处方趋势：一项回顾性队列分析。
Allergy Asthma Clin Immunol. 2015 Jun 10;11(1):19. doi: 10.1186/s13223-015-0085-x. eCollection 2015.
5
Bioavailability of House Dust Mite Allergens in Sublingual Allergy Tablets Is Highly Dependent on the Formulation.舌下过敏片剂中屋尘螨过敏原的生物利用度高度依赖于制剂。
Int Arch Allergy Immunol. 2017;174(1):26-34. doi: 10.1159/000479693. Epub 2017 Sep 27.
6
Clinical efficacy of sublingual immunotherapy tablets for allergic rhinitis is unlikely to be derived from allergen-release data.舌下免疫治疗片剂治疗过敏性鼻炎的临床疗效不太可能源自过敏原释放数据。
Expert Rev Clin Immunol. 2019 Sep;15(9):921-928. doi: 10.1080/1744666X.2019.1649597. Epub 2019 Aug 12.
7
Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis.舌下片剂的屋尘螨变应原提取物在成人过敏性鼻炎中的疗效和安全性。
J Allergy Clin Immunol. 2014 Jun;133(6):1608-14.e6. doi: 10.1016/j.jaci.2013.11.012. Epub 2013 Dec 31.
8
Sublingual immunotherapy tablets as a disease-modifying add-on treatment option to pharmacotherapy for allergic rhinitis and asthma.舌下免疫治疗片作为变应性鼻炎和哮喘药物治疗的一种疾病修饰性附加治疗选择。
Postgrad Med. 2017 Aug;129(6):581-589. doi: 10.1080/00325481.2017.1308208. Epub 2017 Mar 27.
9
The Importance of Tablet Formulation on Allergen Release Kinetics and Efficiency: Comparison of Freeze-dried and Compressed Grass Pollen Sublingual Allergy Immunotherapy Tablet Formulations.片剂配方对过敏原释放动力学和效率的重要性：冻干和压缩的舌下草花粉变应原免疫治疗片剂配方的比较。
Clin Ther. 2019 Apr;41(4):742-753. doi: 10.1016/j.clinthera.2019.02.008. Epub 2019 Mar 16.
10
A practical guide to the sublingual immunotherapy tablet adverse event profile: implications for clinical practice.舌下免疫治疗片剂不良事件概况实用指南：对临床实践的启示
Postgrad Med. 2017 Aug;129(6):590-597. doi: 10.1080/00325481.2017.1302306. Epub 2017 Mar 22.

引用本文的文献

1
Increased IDO expression and regulatory T cells in acute myeloid leukemia: implications for immune escape and therapeutic targeting.急性髓系白血病中吲哚胺2,3-双加氧酶表达增加及调节性T细胞：对免疫逃逸和治疗靶点的影响
Blood Res. 2024 Dec 18;59(1):42. doi: 10.1007/s44313-024-00048-0.
2
Sublingual immunotherapy tablet for the treatment of house dust mite allergic rhinitis in Canada: an alternative to minimize treatment costs?加拿大用于治疗屋尘螨过敏性鼻炎的舌下免疫治疗片剂：一种降低治疗成本的替代方法？
Allergy Asthma Clin Immunol. 2019 Apr 27;15:27. doi: 10.1186/s13223-019-0344-3. eCollection 2019.
3
The complex pathophysiology of allergic rhinitis: scientific rationale for the development of an alternative treatment option.过敏性鼻炎复杂的病理生理学：开发替代治疗方案的科学依据。
Allergy Asthma Clin Immunol. 2019 Apr 16;15:24. doi: 10.1186/s13223-018-0314-1. eCollection 2019.

本文引用的文献

1
Allergy immunotherapy: what is the evidence for cost saving?过敏免疫疗法：节省成本的证据有哪些？
Curr Opin Allergy Clin Immunol. 2014 Aug;14(4):363-70. doi: 10.1097/ACI.0000000000000084.
2
Sublingual or subcutaneous immunotherapy for seasonal allergic rhinitis: an indirect analysis of efficacy, safety and cost.舌下或皮下免疫疗法治疗季节性变应性鼻炎：疗效、安全性和成本的间接分析。
J Eval Clin Pract. 2014 Jun;20(3):225-38. doi: 10.1111/jep.12112. Epub 2014 Jan 21.
3
Efficacy of sublingual immunotherapy for allergic asthma: retrospective meta-analysis of randomized, double-blind and placebo-controlled trials.舌下免疫疗法治疗过敏性哮喘的疗效：随机、双盲、安慰剂对照试验的回顾性荟萃分析。
Clin Respir J. 2014 Apr;8(2):192-205. doi: 10.1111/crj.12058. Epub 2014 Mar 5.
4
Post-treatment efficacy of discontinuous treatment with 300IR 5-grass pollen sublingual tablet in adults with grass pollen-induced allergic rhinoconjunctivitis.成人花粉变应性鼻结膜炎患者用 300IR 5 草花粉舌下片间断治疗的疗效。
Clin Exp Allergy. 2013 May;43(5):568-77. doi: 10.1111/cea.12100.
5
Subcutaneous and sublingual immunotherapy for seasonal allergic rhinitis: a systematic review and indirect comparison.皮下和舌下免疫疗法治疗季节性变应性鼻炎：系统评价和间接比较。
J Allergy Clin Immunol. 2013 May;131(5):1361-6. doi: 10.1016/j.jaci.2013.02.013. Epub 2013 Apr 1.
6
Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review.舌下免疫疗法治疗变应性鼻结膜炎和哮喘的系统评价。
JAMA. 2013 Mar 27;309(12):1278-88. doi: 10.1001/jama.2013.2049.
7
Sub-lingual immunotherapy: world allergy organization position paper 2009.舌下免疫疗法：世界过敏组织2009年立场文件
World Allergy Organ J. 2009 Nov;2(11):233-81. doi: 10.1097/WOX.0b013e3181c6c379. Epub 2009 Nov 19.
8
The burden of allergic rhinitis (AR) in Canada: perspectives of physicians and patients.加拿大变应性鼻炎（AR）的负担：医生和患者的观点。
Allergy Asthma Clin Immunol. 2012 Jun 1;8(1):7. doi: 10.1186/1710-1492-8-7.
9
SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial.舌下标准化草免疫治疗：3 年治疗后 2 年的随机试验中疾病改善的确认。
J Allergy Clin Immunol. 2012 Mar;129(3):717-725.e5. doi: 10.1016/j.jaci.2011.12.973. Epub 2012 Jan 29.
10
Multiple-allergen and single-allergen immunotherapy strategies in polysensitized patients: looking at the published evidence.多过敏原和单过敏原免疫治疗策略在多敏患者中的应用：基于现有研究证据的探讨。
J Allergy Clin Immunol. 2012 Apr;129(4):929-34. doi: 10.1016/j.jaci.2011.11.019. Epub 2012 Jan 11.